Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277744 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT01277744: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01277744 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01277744, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if heated intra-abdominal cisplatin can help to control abdominal tumors in patients having surgery to remove the tumors. The safety of this drug will also be studied.
Interventions
- DRUG Cisplatin
- PROCEDURE Hyperthermic Peritoneal Perfusion (HIPEC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-05-09 |
| Est. Completion | 2018-02-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01277744
The ClinicalTrials.gov registry entry for NCT01277744 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cisplatin is the first listed.
NCT01277744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01277744 about?
NCT01277744 is a clinical study titled "Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor". The goal of this clinical research study is to learn if heated intra-abdominal cisplatin can help to control abdominal tumors in patients having surgery to remove the tumors. The safety of this drug will also be studied.
What is the current status of trial NCT01277744?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2011-05-09. Estimated completion is 2018-02-16.
What interventions are being tested in trial NCT01277744?
The interventions under investigation include: Cisplatin (DRUG), Hyperthermic Peritoneal Perfusion (HIPEC) (PROCEDURE).
Who is sponsoring clinical trial NCT01277744?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.